Cargando…
Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
Numerous clinical studies have established the debilitating neurocognitive side effects of chemotherapy in the treatment of breast cancer, often referred as chemobrain. We hypothesize that cognitive impairments are associated with elevated microglial inflammation in the brain. Thus, either eliminati...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868786/ https://www.ncbi.nlm.nih.gov/pubmed/31753024 http://dx.doi.org/10.1186/s40478-019-0838-8 |